ReviewEuropean journal of clinical pharmacology2013
Therapeutic drug monitoring for tomorrow.
Review in European journal of clinical pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Optimization of the composition of temperature-responsive polymers for spin columns.Scientific reports · 2026Article
- Percutaneous extraction using sponge spicules for disease diagnosis and therapeutic drug monitoring.Scientific reports · 2025Article
- Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol.Acta oncologica (Stockholm, Sweden) · 2025Article
- Innovative Solid-Phase Extraction Strategies for Improving the Advanced Chromatographic Determination of Drugs in Challenging Biological Samples.Molecules (Basel, Switzerland) · 2024Review
- Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review.Pharmacogenomics · 2024Article
- Revolutionizing Precision Medicine: Exploring Wearable Sensors for Therapeutic Drug Monitoring and Personalized Therapy.Biosensors · 2023Review
- Solid Phase-Based Microextraction Techniques in Therapeutic Drug Monitoring.Pharmaceutics · 2023Review
- Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey.Frontiers in pharmacology · 2022Article
- Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer.Clinical lung cancer · 2021Article
- Towards wearable and implantable continuous drug monitoring: A review.Journal of pharmaceutical analysis · 2021Review
- Therapeutic Drug Monitoring of Tigecycline in 67 Infected Patients and a Population Pharmacokinetics/Microbiological Evaluation ofFrontiers in microbiology · 2021Article
- Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.European journal of clinical pharmacology · 2020Article
- SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.European journal of clinical pharmacology · 2019Article
- Article
- External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.British journal of clinical pharmacology · 2018Article
- Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees.Frontiers in pharmacology · 2017Review
- In vivo Raman measurement of levofloxacin lactate in blood using a nanoparticle-coated optical fiber probe.Biomedical optics express · 2016Article
- A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?British journal of clinical pharmacology · 2016Article
- Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2015Article
- Prevalence of Therapeutic Drug Monitoring for Antidepressants and Antipsychotics in Stockholm, Sweden: A Longitudinal Analysis.Therapeutic drug monitoring · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Therapeutic drug monitoring (TDM) represents an early approach to personalised medicine. It helps the clinician to individualise drug treatment and guide dosage to reach systemic drug concentrations associated with therapeutic efficacy and/or to reduce the risk of concentration-dependent adverse effects. Well into the fifth decade of TDM as a service to healthcare, this concept is still expanding, and new areas for clinical implementation continue to emerge. The aim of this overview is to discuss promising new therapeutic areas in future TDM services, how to improve the clinical interpretation of single drug measurements and how recent technology development opens the doors to research and new applications.
Indexed as
Identifiers
23640185What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.